Substance use disorder/ Substance abuse or dependence (psychoactive substances other than alcohol and tobacco)
Conditions
Interventions
A weekly 6-session web-based cognitive behavioral relapse prevention program (about 60 minutes per session), web-based day-by-day self-monitoring, provision of relevant information, and usual outpatie
Sponsors
Department of Psychiatric Nursing, Graduate School of Medicine, The University of Tokyo
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Outpatients who were diagnosed with substance use disorder (abuse or dependence) assessed by DSM-IV or V (psychoactive substances other than alcohol and tobacco) 2) Those who used a primary abused drug in the past year 3) Those with access to the Internet via PC, smartphone or tablet computer and can exchange e-mail.
Exclusion criteria
Exclusion criteria: 1) Patients with severe physical diseases 2) Patients with high suicide risk 3) Patients with severe symptoms of substance-induced psychotic disorder 4) Patients with impaired cognitive function 5) Those judged ineligible to participate in the study by a psychiatrist.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) Relapse risk (assessed by the Stimulant Relapse Risk Scale) assessment at the 8th (immediately after intervention), 20th and 32nd week after start of intervention 2) The longest period of abstinent days from primary abused drug during the 56-day intervention period (assessed by self-reports using the self-monitoring calendar) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)-10) at assessments in the 8th (immediately after intervention), 20th and 32nd week after start of intervention 1) Motivation toward treatment and behavioral change (assessed by the Stage of Change Readiness and Treatment Eagerness Scale 8D) 2) Confidence in dealing with drug use cravings (assessed by Self-efficacy Scale for Drug Dependence) 3) Percentage of days abstinent from primary abused drug in the past 28 or 56 days (assessed by self-reports using the self-monitoring calendar or the Timeline Follow-back method) 4) Changes in the period of abstinent days from primary abused drug in the past 28 days (assessed by self-reports using the self-monitoring calendar or the Timeline Follow-Back method) 5) Expenses for drugs or alcohol in the last month 6) Retention in outpatient treatment (yes or no) 7) Involvement in self-help groups (yes or no) 8) Use of rehabilitation facilities (yes or no) 9) Health related QOL (assessed by WHOQOL26) 10) Sense of coherence (assessed by 3-item sense of coherence scale) 11) At baseline and 32-week follow-up assessment, psychiatric medical cost in the past 6 months (self-reported period and frequency of hospitalization, outpatient visit, prescription and group therapy). | — |
Countries
Japan
Contacts
Public ContactAyumi Takano
Graduate School of Medicine, The University of Tokyo Department of Psychiatric Nursing
Outcome results
None listed